Screening of<unk>  should be obtained in infants who are at risk for<unk> . Surveillance should be continued every three to six hours for the first 48 hours of life. Treatment should be started immediately after a primary blood test.
Hypoglycemia screening
Hypocalcemia screening
Adrenal insufficiency screening
Hyperkalemia screening
Adrenal atrophy screening
Metabolic syndrome screening
Diabetic ketoacidosis screening
Cyanosis screening